Ethyl 7-bromo-2,2-dimethylheptanoate
Ethyl 7-bromo-2,2-dimethylheptanoate Basic information
- Product Name:
- Ethyl 7-bromo-2,2-dimethylheptanoate
- Synonyms:
-
- ethyl-2,2-dimethyl-7-bromoheptanoate
- 7-Bromo-2,2-dimethylheptanoic acid ethyl ester
- ETC-1002 intermediate 2
- ethyl 7-bromo-2,2-dimethylheptanoate
- Heptanoic acid, 7-bromo-2,2-dimethyl-, ethyl ester
- Bempedoic Acid Impurity 9
- Bempedoic acid intermediate
- 7-bromo-2,2-dimethylheptanoate
- CAS:
- 123469-92-1
- MF:
- C11H21BrO2
- MW:
- 265.19
- Mol File:
- 123469-92-1.mol
Ethyl 7-bromo-2,2-dimethylheptanoate Chemical Properties
- Boiling point:
- 106-108 °C(Press: 0.01 Torr)
- Density
- 1.169±0.06 g/cm3(Predicted)
- vapor pressure
- 0.0±0.6 mmHg at 25°C
- refractive index
- 1.463
- Flash point:
- 146.4±13.0 °C
- storage temp.
- Store at room temperature
- Appearance
- Colorless to light yellow Liquid
- InChI
- InChI=1S/C11H21BrO2/c1-4-14-10(13)11(2,3)8-6-5-7-9-12/h4-9H2,1-3H3
- InChIKey
- SYRIIFZUZOIRNU-UHFFFAOYSA-N
- SMILES
- C(OCC)(=O)C(C)(C)CCCCCBr
- LogP
- 3.92
Ethyl 7-bromo-2,2-dimethylheptanoate Usage And Synthesis
Description
Ethyl 7-bromo-2,2-dimethylheptanoate is an important raw material in the synthesis route of bepetidic acid. Bempedoic acid, whose chemical name is 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid, also known as ETC-1002, is a new type of lipid developed by the American EsperionTherapeutic company Quality regulation small molecule drugs. As one of the company's main drug candidates, its targets are liver adenosine triphosphate-citrate lyase (ACL) and adenosine monophosphate-activated protein kinase (AMPK).
Uses
Ethyl-2,2-dimethyl-7-bromoheptanoate can be used as an intermediate in organic synthesis, mainly used in laboratory research and development and chemical production processes.
Synthesis
Ethyl 7-bromo-2,2-dimethylheptanoate is obtained from ethyl isobutyrate and 1,5-dibromopentane as starting materials, undergoing a reaction with lithium diisopropylamide (LDA) at low temperatures.
Synthesis
The specific embodiment of the present invention is as follows: prepare 19.4g (167mmol) of ethyl isobutyrate in 216mL solution of tetrahydrofuran with a mass concentration of 10%, connect to metering pump 1; prepare 84mL (168mmol) of 2.0M n-butyllithium solution, connect to meter Pump 2; configure 1,5-dibromopentane 80.0g (348mmol) tetrahydrofuran 100mL solution, mass concentration is 63%, connected to metering pump 3.Configure 300mL of 1N hydrochloric acid solution and connect to metering pump 4.Set continuous flow precooler 1, the circulating temperature is 0, and reach stability; set continuous flow precooler 2, the circulating temperature is 0, and reach stability; set continuous flow precooler 3, and the circulating temperature is 0, and reach stability; set continuous flow precooler 4, cycle temperature is 0, and reach stability;Set the flow rate of metering pump 1 to 65.0ml/min, set the flow rate of metering pump 2 to 25.0ml/min, set the flow rate of metering pump 3 to 30.0ml/min, and set the flow rate of metering pump 4 to 90.0ml/min.Turn on the metering pump 1 and metering pump 2 at the same time. After 60s of operation, turn on the metering pump 3, and after 60s of operation, turn on the metering pump 4 to collect the outflowing reaction liquid in the storage tank.After the operation is completed, separate the liquids, collect the upper organic phase, concentrate under reduced pressure at P=-0.08MPa, T=45C to remove low-boiling solvents, and then rectify under reduced pressure at P=5mmHg and T=70C to obtain 38.4 g.The obtained product is a colorless liquid with a GC purity of 98.6% and a yield of 87%.
Ethyl 7-bromo-2,2-dimethylheptanoateSupplier
- Tel
- 028-82666846 18080826311
- sales@astatech.com.cn
- Tel
- 13626608877
- sales@pancare.com.cn
- Tel
- 02136680027 15800370750
- 1706640024@qq.com
- Tel
- 18519331287; 18519331287
- 1751713684@qq.com
- Tel
- 0432-62601618 13756693631
- wangjiaqi@lianben.com